NFE2L2 and neoplasm: We tested Luteolin, which is BBB-permeable, has an established safety profile in humans36,40 and potently decreases Nrf2 levels when it is over-activated (e.g. in tumours or in gain-of-function mutations36,41,42), as observed in our in vitro assays (Fig. 5).